{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:17:41Z","timestamp":1778249861953,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11626-025-01149-5","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:58:23Z","timestamp":1776272303000},"page":"428-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncogenic role and potential mechanisms of MYO1B in breast cancer"],"prefix":"10.1007","volume":"62","author":[{"given":"Mei","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0586-4284","authenticated-orcid":false,"given":"Danhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"1149_CR1","unstructured":"Ahmadzadeh ELF (2017) Paclitaxel resistance in triple negative breast cancer involves novel functional genomic aberrations in the ABCB1 gene. GSE90564"},{"key":"1149_CR2","doi-asserted-by":"publisher","unstructured":"Ahn S, Park JH, Grimm SL, Piyarathna DWB, Samanta T, Putluri V, Mezquita D, Fuqua SAW et al (2024) Metabolomic rewiring promotes endocrine therapy resistance in breast cancer. Cancer Res 84(2):291\u2013304. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0184","DOI":"10.1158\/0008-5472.Can-23-0184"},{"key":"1149_CR3","doi-asserted-by":"publisher","unstructured":"Alves CL, Ditzel HJ (2023) Drugging the PI3K\/AKT\/mTOR pathway in ER+ breast cancer. Int J Mol Sci 24(5):4522. https:\/\/doi.org\/10.3390\/ijms24054522","DOI":"10.3390\/ijms24054522"},{"issue":"1","key":"1149_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74083-z","volume":"10","author":"A Barkovskaya","year":"2020","unstructured":"Barkovskaya A, Seip K, Prasmickaite L, Mills IG, Moestue SA, Itkonen HM (2020) Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells. Sci Rep 10(1):16992. https:\/\/doi.org\/10.1038\/s41598-020-74083-z","journal-title":"Sci Rep"},{"key":"1149_CR5","doi-asserted-by":"publisher","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH et al (2013) NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res 41(Database issue):D991\u2013D995. https:\/\/doi.org\/10.1093\/nar\/gks1193","DOI":"10.1093\/nar\/gks1193"},{"key":"1149_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052622","author":"\u00c1 Bartha","year":"2021","unstructured":"Bartha \u00c1, Gy\u0151rffy B (2021) TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22052622","journal-title":"Int J Mol Sci"},{"key":"1149_CR7","unstructured":"Bayram OYCA (2024) Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer. GSE262353"},{"key":"1149_CR8","doi-asserted-by":"publisher","unstructured":"Braunstein M, Liao L, Lyttle N, Lobo N, Taylor KJ, Krzyzanowski PM, Kalatskaya I, Yao CQ et al (2016) Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer. Breast Cancer Res 18(1):16. https:\/\/doi.org\/10.1186\/s13058-016-0676-6","DOI":"10.1186\/s13058-016-0676-6"},{"key":"1149_CR9","doi-asserted-by":"publisher","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS et al (2022) Ualcan: an update to the integrated cancer data analysis platform. Neoplasia 25:18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001","DOI":"10.1016\/j.neo.2022.01.001"},{"key":"1149_CR10","doi-asserted-by":"publisher","unstructured":"Chapman BV, Wald AI, Akhtar P, Munko AC, Xu J, Gibson SP, Grandis JR, Ferris RL et al (2015) Microrna-363 targets myosin 1B to reduce cellular migration in head and neck cancer. BMC Cancer 15(1):861. https:\/\/doi.org\/10.1186\/s12885-015-1888-3","DOI":"10.1186\/s12885-015-1888-3"},{"issue":"31","key":"1149_CR11","doi-asserted-by":"publisher","first-page":"21575","DOI":"10.1074\/jbc.274.31.21575","volume":"274","author":"LM Coluccio","year":"1999","unstructured":"Coluccio LM, Geeves MA (1999) Transient kinetic analysis of the 130-kDa myosin I (MYR-1 gene product) from rat liver: a myosin I designed for maintenance of tension? J Biol Chem 274(31):21575\u201321580. https:\/\/doi.org\/10.1074\/jbc.274.31.21575","journal-title":"J Biol Chem"},{"issue":"12","key":"1149_CR12","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1091\/mbc.12.12.4013","volume":"12","author":"MN Cordonnier","year":"2001","unstructured":"Cordonnier MN, Dauzonne D, Louvard D, Coudrier E (2001) Actin filaments and myosin I alpha cooperate with microtubules for the movement of lysosomes. Mol Biol Cell 12(12):4013\u20134029. https:\/\/doi.org\/10.1091\/mbc.12.12.4013","journal-title":"Mol Biol Cell"},{"key":"1149_CR13","doi-asserted-by":"publisher","unstructured":"Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG et al (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403):346\u2013352. https:\/\/doi.org\/10.1038\/nature10983Accessed","DOI":"10.1038\/nature10983Accessed"},{"key":"1149_CR14","doi-asserted-by":"publisher","unstructured":"Diz-Mu\u00f1oz A, Krieg M, Bergert M, Ibarlucea-Benitez I, Muller DJ, Paluch E, Heisenberg CP et al (2010) Control of directed cell migration in vivo by membrane-to-cortex attachment. PLoS Biol 8(11):e1000544. https:\/\/doi.org\/10.1371\/journal.pbio.1000544","DOI":"10.1371\/journal.pbio.1000544"},{"issue":"7121","key":"1149_CR15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315(7121):1533\u20131537. https:\/\/doi.org\/10.1136\/bmj.315.7121.1533","journal-title":"BMJ"},{"key":"1149_CR16","doi-asserted-by":"publisher","unstructured":"Elias D, Vever H, L\u00e6nkholm AV, Gjerstorff MF, Yde CW, Lykkesfeldt AE, Ditzel HJ et al (2015) Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy. Oncogene 34(15):1919\u20131927. https:\/\/doi.org\/10.1038\/onc.2014.138","DOI":"10.1038\/onc.2014.138"},{"issue":"11","key":"1149_CR17","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","volume":"145","author":"JT Fekete","year":"2019","unstructured":"Fekete JT, Gy\u0151rffy B (2019) ROCplot.org: validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J Cancer 145(11):3140\u20133151. https:\/\/doi.org\/10.1002\/ijc.32369","journal-title":"Int J Cancer"},{"key":"1149_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115991","volume":"220","author":"M Feng","year":"2024","unstructured":"Feng M, Santhanam RK, Xing H, Zhou M, Jia H (2024) Inhibition of \u03b3-secretase\/Notch pathway as a potential therapy for reversing cancer drug resistance. Biochem Pharmacol 220:115991. https:\/\/doi.org\/10.1016\/j.bcp.2023.115991","journal-title":"Biochem Pharmacol"},{"key":"1149_CR19","doi-asserted-by":"publisher","unstructured":"Ferro A, Campora M, Caldara A, De Lisi D, Lorenzi M, Monteverdi S, Mihai R, Bisio A et al (2024) Novel treatment strategies for hormone receptor (HR)-positive, HER2-negative metastatic breast cancer. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13123611","DOI":"10.3390\/jcm13123611"},{"issue":"6","key":"1149_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4193\/Rhin19.406","volume":"57","author":"WJ Fokkens","year":"2019","unstructured":"Fokkens WJ (2019) The advantage of sytematic reviews and meta-analysis. Rhinology 57(6):401. https:\/\/doi.org\/10.4193\/Rhin19.406","journal-title":"Rhinology"},{"key":"1149_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136853","author":"S Foutadakis","year":"2024","unstructured":"Foutadakis S, Kordias D, Vatsellas G, Magklara A (2024) Identification of new chemoresistance-associated genes in triple-negative breast cancer by single-cell transcriptomic analysis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25136853","journal-title":"Int J Mol Sci"},{"issue":"28","key":"1149_CR22","doi-asserted-by":"publisher","first-page":"21624","DOI":"10.1074\/jbc.M000342200","volume":"275","author":"MA Geeves","year":"2000","unstructured":"Geeves MA, Perreault-Micale C, Coluccio LM (2000) Kinetic analyses of a truncated mammalian myosin I suggest a novel isomerization event preceding nucleotide binding. J Biol Chem 275(28):21624\u201321630. https:\/\/doi.org\/10.1074\/jbc.M000342200","journal-title":"J Biol Chem"},{"key":"1149_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112509","volume":"137","author":"A Gholami","year":"2024","unstructured":"Gholami A (2024) Cancer stem cell-derived exosomes in CD8(+) T cell exhaustion. Int Immunopharmacol 137:112509. https:\/\/doi.org\/10.1016\/j.intimp.2024.112509","journal-title":"Int Immunopharmacol"},{"key":"1149_CR24","doi-asserted-by":"publisher","unstructured":"Glaviano A, Wander SA, Baird RD, Yap KC, Lam HY, Toi M, Carbone D, Geoerger B et al (2024) Mechanisms of sensitivity and resistance to CDK4\/CDK6 inhibitors in hormone receptor-positive breast cancer treatment. Drug Resist Updat. 76:101103. https:\/\/doi.org\/10.1016\/j.drup.2024.101103","DOI":"10.1016\/j.drup.2024.101103"},{"key":"1149_CR25","doi-asserted-by":"publisher","unstructured":"Gonzalez-Malerva L, Park J, Zou L, Hu Y, Moradpour Z, Pearlberg J, Sawyer J, Stevens H et al (2011) High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci USA 108(5):2058\u20132063. https:\/\/doi.org\/10.1073\/pnas.1018157108","DOI":"10.1073\/pnas.1018157108"},{"issue":"23","key":"1149_CR26","doi-asserted-by":"publisher","first-page":"7196","DOI":"10.1158\/1078-0432.Ccr-09-0585","volume":"15","author":"L Gu","year":"2009","unstructured":"Gu L, Lau SK, Loera S, Somlo G, Kane SE (2009) Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines. Clin Cancer Res 15(23):7196\u20137206. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-09-0585","journal-title":"Clin Cancer Res"},{"key":"1149_CR27","doi-asserted-by":"publisher","unstructured":"Harris MA, Savas P, Virassamy B, O'Malley MMR, Kay J, Mueller SN, Mackay LK, Salgado R et al (2024) Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer 24(8):554\u2013577. https:\/\/doi.org\/10.1038\/s41568-024-00714-6","DOI":"10.1038\/s41568-024-00714-6"},{"key":"1149_CR28","doi-asserted-by":"publisher","unstructured":"J\u00e9z\u00e9quel P, Gouraud W, Ben Azzouz F, Gu\u00e9rin-Charbonnel C, Juin PP, Lasla H et al (2021) bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database (Oxford). https:\/\/doi.org\/10.1093\/database\/baab007","DOI":"10.1093\/database\/baab007"},{"key":"1149_CR29","doi-asserted-by":"crossref","unstructured":"Jones CJSM (2021) Development and characterization of a novel endoxifen-resistant breast cancer cell line highlights numerous differences from tamoxifen-resistant models. GSE164529","DOI":"10.1158\/1541-7786.MCR-20-0872"},{"key":"1149_CR30","doi-asserted-by":"publisher","first-page":"1443366","DOI":"10.3389\/fimmu.2024.1443366","volume":"15","author":"H Jung","year":"2024","unstructured":"Jung H, Paust S (2024) Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy. Front Immunol 15:1443366. https:\/\/doi.org\/10.3389\/fimmu.2024.1443366","journal-title":"Front Immunol"},{"key":"1149_CR31","doi-asserted-by":"publisher","unstructured":"Khan IR, Sadida HQ, Hashem S, Singh M, Macha MA, Al-Shabeeb Akil AS, Khurshid I, Bhat AA et al (2024) Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer. Biomed Pharmacother 176:116873. https:\/\/doi.org\/10.1016\/j.biopha.2024.116873","DOI":"10.1016\/j.biopha.2024.116873"},{"key":"1149_CR32","doi-asserted-by":"publisher","unstructured":"Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, Fulton LL, Dooling DJ et al (2012) Comprehensive molecular portraits of human breast tumours. Nature. 490(7418):61\u201370. https:\/\/doi.org\/10.1038\/nature11412","DOI":"10.1038\/nature11412"},{"key":"1149_CR33","doi-asserted-by":"publisher","unstructured":"Lanceta L, Lypova N, O'Neill C, Li X, Rouchka E, Chesney J, Imbert-Fernandez Y et al (2021) Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq. Breast Cancer Res Treat 186(3):677\u2013686. https:\/\/doi.org\/10.1007\/s10549-021-06127-5","DOI":"10.1007\/s10549-021-06127-5"},{"key":"1149_CR34","doi-asserted-by":"publisher","unstructured":"Li S-H, Qian L, Chen Y-H, Lu H-I, Tsai H-T, Lyu H, Yang R, Chen C-H et al (2022) Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2\/cyclin D1 signaling in esophageal squamous cell carcinoma. J Cell Physiol 237(9):3671\u20133686. https:\/\/doi.org\/10.1002\/jcp.30831","DOI":"10.1002\/jcp.30831"},{"key":"1149_CR35","doi-asserted-by":"publisher","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","DOI":"10.1093\/nar\/gkaa407"},{"key":"1149_CR36","doi-asserted-by":"publisher","unstructured":"Navarro-Yepes J, Kettner NM, Rao X, Bishop CS, Bui TN, Wingate HF, Singareeka Raghavendra A, Wang Y et al (2023) Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers. Cancer Res 83(19):3264\u20133283. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0705","DOI":"10.1158\/0008-5472.Can-23-0705"},{"key":"1149_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"C Ngambenjawong","year":"2017","unstructured":"Ngambenjawong C, Gustafson HH, Pun SH (2017) Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 114:206\u2013221. https:\/\/doi.org\/10.1016\/j.addr.2017.04.010","journal-title":"Adv Drug Deliv Rev"},{"key":"1149_CR38","doi-asserted-by":"publisher","unstructured":"Nunnery SE, Mayer IA (2020) Targeting the PI3K\/AKT\/mTOR pathway in hormone-positive breast cancer. Drugs 80(16):1685\u20131697. https:\/\/doi.org\/10.1007\/s40265-020-01394-w","DOI":"10.1007\/s40265-020-01394-w"},{"issue":"5","key":"1149_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira G, Wu CJ (2023) Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer 23(5):295\u2013316. https:\/\/doi.org\/10.1038\/s41568-023-00560-y","journal-title":"Nat Rev Cancer"},{"key":"1149_CR40","doi-asserted-by":"publisher","unstructured":"Ortega MA, Boaru DL, De Leon-Oliva D, Fraile-Martinez O, Garc\u00eda-Montero C, Rios L, Garrido-Gil MJ, Barrena-Bl\u00e1zquez S et al (2024) PD-1\/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications. J Mol Med (Berl) 102(8):987\u20131000. https:\/\/doi.org\/10.1007\/s00109-024-02463-3","DOI":"10.1007\/s00109-024-02463-3"},{"key":"1149_CR41","doi-asserted-by":"publisher","unstructured":"Pancholi S, Ribas R, Simigdala N, Schuster E, Nikitorowicz-Buniak J, Ressa A, Gao Q, Leal MF et al (2020) Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities. Oncogene 39(25):4781\u20134797. https:\/\/doi.org\/10.1038\/s41388-020-1284-6","DOI":"10.1038\/s41388-020-1284-6"},{"issue":"1","key":"1149_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","volume":"56","author":"J Park","year":"2023","unstructured":"Park J, Hsueh PC, Li Z, Ho PC (2023) Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity. Immunity 56(1):32\u201342. https:\/\/doi.org\/10.1016\/j.immuni.2022.12.008","journal-title":"Immunity"},{"issue":"Suppl 5","key":"1149_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"SJ Park","year":"2019","unstructured":"Park SJ, Yoon BH, Kim SK, Kim SY (2019) GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics 12(Suppl 5):101. https:\/\/doi.org\/10.1186\/s12920-019-0514-7","journal-title":"BMC Med Genomics"},{"key":"1149_CR44","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Pena J, P\u00e1ez R, Nieto-Jim\u00e9nez C, S\u00e1nchez VC, Galan-Moya EM, Pandiella A, Gy\u0151rffy B, Ocana A et al (2019) Mapping bromodomains in breast cancer and association with clinical outcome. Sci Rep 9(1):5734. https:\/\/doi.org\/10.1038\/s41598-019-41934-3","DOI":"10.1038\/s41598-019-41934-3"},{"key":"1149_CR45","doi-asserted-by":"publisher","unstructured":"Prosp\u00e9ri M-T, L\u00e9pine P, Dingli F, Paul-Gilloteaux P, Martin R, Loew D, Kn\u00f6lker H-J, Coudrier E et al (2015) Myosin 1b functions as an effector of EphB signaling to control cell repulsion. J Cell Biol 210(2):347\u2013361. https:\/\/doi.org\/10.1083\/jcb.201501018","DOI":"10.1083\/jcb.201501018"},{"issue":"8","key":"1149_CR46","doi-asserted-by":"publisher","first-page":"e1800148","DOI":"10.1002\/pmic.201800148","volume":"19","author":"A Rai","year":"2019","unstructured":"Rai A, Greening DW, Chen M, Xu R, Ji H, Simpson RJ (2019) Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome. Proteomics 19(8):e1800148. https:\/\/doi.org\/10.1002\/pmic.201800148","journal-title":"Proteomics"},{"key":"1149_CR47","doi-asserted-by":"crossref","unstructured":"Raposo G, Cordonnier M-N, Tenza D, Menichi B, Durrbach A, Louvard D, Coudrier E et al (1999) Association of myosin I alpha with endosomes and lysosomes in mammalian cells. Mol Biol Cell 10(5):1477\u20131494","DOI":"10.1091\/mbc.10.5.1477"},{"issue":"6","key":"1149_CR48","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1083\/jcb.120.6.1393","volume":"120","author":"C Ruppert","year":"1993","unstructured":"Ruppert C, Kroschewski R, B\u00e4hler M (1993) Identification, characterization and cloning of myr 1, a mammalian myosin-I. J Cell Biol 120(6):1393\u20131403. https:\/\/doi.org\/10.1083\/jcb.120.6.1393","journal-title":"J Cell Biol"},{"key":"1149_CR49","doi-asserted-by":"publisher","unstructured":"Saal LH, Vallon-Christersson J, H\u00e4kkinen J, Hegardt C, Grabau D, Winter C, Brueffer C, Tang MH\u00a0et al (2015) The Sweden cancerome analysis network - breast (SCAN-B) initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med 7(1):20. https:\/\/doi.org\/10.1186\/s13073-015-0131-9","DOI":"10.1186\/s13073-015-0131-9"},{"key":"1149_CR50","doi-asserted-by":"publisher","unstructured":"Salas-Cortes L, Ye F, Tenza D, Wilhelm C, Theos A, Louvard D, Raposo G, Coudrier E et al (2005) Myosin Ib modulates the morphology and the protein transport within multi-vesicular sorting endosomes. J Cell Sci 118(Pt 20):4823\u20134832. https:\/\/doi.org\/10.1242\/jcs.02607","DOI":"10.1242\/jcs.02607"},{"key":"1149_CR51","doi-asserted-by":"publisher","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W et al (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 50(W1):W216-w221. https:\/\/doi.org\/10.1093\/nar\/gkac194","DOI":"10.1093\/nar\/gkac194"},{"issue":"1","key":"1149_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41598-020-78624-4","volume":"11","author":"SV Thangaraj","year":"2021","unstructured":"Thangaraj SV, Shyamsundar V, Krishnamurthy A, Ramshankar V (2021) Deregulation of extracellular matrix modeling with molecular prognostic markers revealed by transcriptome sequencing and validations in oral tongue squamous cell carcinoma. Sci Rep 11(1):250. https:\/\/doi.org\/10.1038\/s41598-020-78624-4","journal-title":"Sci Rep"},{"key":"1149_CR53","doi-asserted-by":"publisher","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C et al (2015) Tissue-based map of the human proteome. Science 347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419","DOI":"10.1126\/science.1260419"},{"key":"1149_CR54","doi-asserted-by":"publisher","unstructured":"Varadan V, Gilmore H, Miskimen KL, Tuck D, Parsai S, Awadallah A, Krop IE, Winer EP et al (2016) Immune signatures following single dose trastuzumab predict pathologic response to preoperativetrastuzumab and chemotherapy in HER2-positive early breast cancer. Clin Cancer Res 22(13):3249\u20133259. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2021","DOI":"10.1158\/1078-0432.Ccr-15-2021"},{"key":"1149_CR55","doi-asserted-by":"publisher","unstructured":"Walbaum B, Garc\u00eda-Fructuoso I, Mart\u00ednez-S\u00e1ez O, Schettini F, S\u00e1nchez C, Acevedo F, Chic N, Mu\u00f1oz-Carrillo J et al (2024) Hormone receptor-positive early breast cancer in young women: a comprehensive review. Cancer Treat Rev 129:102804. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102804","DOI":"10.1016\/j.ctrv.2024.102804"},{"key":"1149_CR56","unstructured":"Wen L-J, Hu X-L, Li C-Y, Liu J, Li Z-Y, Li Y-Z, Zhou J-Y et al (2021) Myosin 1b promotes migration, invasion and glycolysis in cervical cancer via ERK\/HIF-1\u03b1 pathway. Am J Transl Res 13(11):12536\u201312548"},{"issue":"4","key":"1149_CR57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cm.970200406","volume":"20","author":"D Wessels","year":"1991","unstructured":"Wessels D, Murray J, Jung G, Hammer JA 3rd, Soll DR (1991) Myosin IB null mutants of dictyostelium exhibit abnormalities in motility. Research support, non-U.S. Gov\u2019t; research support, U.S. Gov\u2019t, P.H.S. Cell Motil Cytoskeleton. 20(4):301\u201315. https:\/\/doi.org\/10.1002\/cm.970200406","journal-title":"Cell Motil Cytoskeleton."},{"key":"1149_CR58","doi-asserted-by":"publisher","unstructured":"Xie L, Huang H, Zheng Z, Yang Q, Wang S, Chen Y, Yu J, Cui C et al (2021) MYO1B enhances colorectal cancer metastasis by promoting the F-actin rearrangement and focal adhesion assembly via RhoA\/ROCK\/FAK signaling. Annals Transl Med 9(20):1543. https:\/\/doi.org\/10.21037\/atm-21-4702","DOI":"10.21037\/atm-21-4702"},{"key":"1149_CR59","unstructured":"Yague EKU (2023) Doxorubicin response in a triple negative breast cancer cell model: long-term resistance versus short-term stress. GSE202536"},{"key":"1149_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.isci.2019.07.010","volume":"19","author":"Y Yu","year":"2019","unstructured":"Yu Y, Xiong Y, Ladeiras D, Yang Z, Ming XF (2019) Myosin 1b regulates nuclear AKT activation by preventing localization of PTEN in the nucleus. iScience 19:39\u201353. https:\/\/doi.org\/10.1016\/j.isci.2019.07.010","journal-title":"iScience"},{"key":"1149_CR61","doi-asserted-by":"publisher","unstructured":"Zhang H-R, Lai S-Y, Huang L-J, Zhang Z-F, Liu J, Zheng S-R, Ding K, Bai X et al (2018) Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer. Gynecol Oncol 149(1):188\u2013197. https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.024","DOI":"10.1016\/j.ygyno.2018.01.024"},{"key":"1149_CR62","doi-asserted-by":"publisher","unstructured":"Zhou W, Zeng T, Chen J, Tang X, Yuan Y, Hu D, Zhang Y, Li Y et al (2024) Aberrant angiogenic signaling pathways: accomplices in ovarian cancer progression and treatment. Cell Signal 120:111240. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111240","DOI":"10.1016\/j.cellsig.2024.111240"},{"key":"1149_CR63","doi-asserted-by":"publisher","unstructured":"Zhu Y, Zheng S, Zhai X, Wang C, Liu A, Ju J, Peng X, Chen L et al (2022) Comprehensive landscape of prognostic significance and immune characteristics of myosins in squamous cell carcinoma of the head and neck. J Immunol Res 2022:5501476. https:\/\/doi.org\/10.1155\/2022\/5501476","DOI":"10.1155\/2022\/5501476"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-025-01149-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-025-01149-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-025-01149-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:00:07Z","timestamp":1778248807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11626-025-01149-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1007\/s11626-025-01149-5","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve any ethical issues.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}